Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
23.85
+0.74 (3.20%)
At close: Mar 9, 2026

BOM:531015 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
191149----
Upgrade
Market Cap Growth
27.91%-----
Upgrade
Enterprise Value
210153----
Upgrade
Last Close Price
23.8528.52----
Upgrade
PS Ratio
4.3318.51----
Upgrade
PB Ratio
2.023.39----
Upgrade
P/TBV Ratio
2.023.39----
Upgrade
EV/Sales Ratio
4.7618.94----
Upgrade
Debt / Equity Ratio
0.350.01-0.54-0.49-0.37-0.84
Upgrade
Debt / FCF Ratio
--160.04-0.188.83
Upgrade
Net Debt / Equity Ratio
0.20-0.55-0.54-0.49-0.37-0.81
Upgrade
Net Debt / EBITDA Ratio
-11.352.34-3.34-1.89-2.74-14.88
Upgrade
Net Debt / FCF Ratio
-0.161.06158.91-113.480.188.54
Upgrade
Asset Turnover
0.440.31---0.44
Upgrade
Quick Ratio
1.204.580.020.040.030.07
Upgrade
Current Ratio
1.946.780.020.150.120.07
Upgrade
Return on Equity (ROE)
21.82%-0.56%----
Upgrade
Return on Assets (ROA)
-1.06%-24.94%-47.69%-56.94%-32.72%-26.49%
Upgrade
Return on Invested Capital (ROIC)
-1.91%-124.82%----
Upgrade
Return on Capital Employed (ROCE)
-1.80%-23.70%17.30%27.30%14.60%5.80%
Upgrade
Earnings Yield
4.57%-0.07%----
Upgrade
FCF Yield
--15.33%----
Upgrade
Buyback Yield / Dilution
-22.02%----0.00%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.